SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-004544
Filing Date
2024-01-08
Accepted
2024-01-08 17:15:25
Documents
3

Document Format Files

Seq Description Document Type Size
1 DFAN14A d700701ddfan14a.htm DFAN14A 39515
2 GRAPHIC g700701g0108081612639.jpg GRAPHIC 3999
3 GRAPHIC g700701g0108081612826.jpg GRAPHIC 3507
  Complete submission text file 0001193125-24-004544.txt   52105
Mailing Address ONE MERCK DR PO BOX 100 WS3AB-05 WHITEHOUSE STATION NJ 08889-0100
Business Address ONE MERCK DR P O BOX 100 WHITEHOUSE STATION NJ 08889-0100 9084231688
MERCK SHARP & DOHME LLC (Filed by) CIK: 0000064978 (see all company filings)

IRS No.: 221109110 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DFAN14A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Subject) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-38800 | Film No.: 24521040
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)